{
  "actions": [
    {
      "acted_at": "2001-01-03", 
      "committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2001-02-07", 
      "in_committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr58-107", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "107", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2001-01-03", 
  "number": "58", 
  "official_title": "To amend section 804 of the Federal Food, Drug, and Cosmetic Act to correct impediments in the implementation of the Medicine Equity and Drug Safety Act of 2000.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Medicine Equity and Drug Safety Act Corrections of 2001", 
  "sponsor": {
    "district": "20", 
    "name": "Deutsch, Peter", 
    "state": "FL", 
    "thomas_id": "00291", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2001-01-03", 
  "subjects": [
    "Administrative procedure", 
    "Authorization", 
    "Commerce", 
    "Congress", 
    "Congressional oversight", 
    "Congressional reporting requirements", 
    "Department of Health and Human Services", 
    "Drug industry", 
    "Drugs", 
    "Economics and public finance", 
    "Fees", 
    "Government operations and politics", 
    "Health", 
    "Imports", 
    "Labeling", 
    "Manufacturing industries", 
    "Pharmacists", 
    "Prescription pricing", 
    "Restrictive trade practices", 
    "Wholesale trade"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2001-01-03", 
    "text": "Medicine Equity and Drug Safety Act Corrections of 2001 - Amends the Medicine Equity and Drug Safety Act of 2000 (section 804 of the Federal Food, Drug, and Cosmetic Act (FDCA), as added to the FDCA by Public Law 106-387) to, among other things: (1) require regulations permitting pharmacists and wholesalers to import into the United States covered products to specify a fair and reasonable fee that a manufacturer may charge an importer for the use of labeling of a covered product; (2) repeal sunset provisions; and (3) authorize appropriations for such Act."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Medicine Equity and Drug Safety Act Corrections of 2001", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "To amend section 804 of the Federal Food, Drug, and Cosmetic Act to correct impediments in the implementation of the Medicine Equity and Drug Safety Act of 2000.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:48:05-05:00"
}